Invesco India Pharma & Healthcare Fund NFO Launched
By Business Desk
Invesco Mutual Fund launches the Invesco India Pharma and Healthcare Fund NFO, open Aug 18 – Sep 1, 2026. Invest in India’s growing healthcare sector.
Invesco Mutual Fund has officially launched the Invesco India Pharma and Healthcare Fund, an open-ended equity scheme designed to tap into India’s evolving pharmaceutical and healthcare sectors. The New Fund Offer (NFO) commenced on August 18, 2026, and will conclude on September 1, 2026.
This new fund seeks to capitalize on the significant structural transformation occurring within India’s healthcare ecosystem. The offering aims to leverage several key drivers shaping the industry’s growth trajectory.
Market Drivers
- Favorable demographics across the nation.
- Increasing access to comprehensive healthcare services.
- Rising penetration of health insurance coverage.
- India’s growing global leadership as a pharmaceutical and innovation hub.
The fund’s investment strategy is broad, encompassing various segments across the entire healthcare value chain. This includes a diverse portfolio of companies within the sector.
Fund Specifics
- Fund Manager: Aditya Khemani.
- Benchmark: BSE Healthcare TRI.
- Minimum Lump Sum Investment: Rs 1,000.
- Minimum SIP Investment: Rs 100.
- Exit Load: 0.50% for redemptions or switches within three months from allotment.
The Invesco India Pharma and Healthcare Fund offers investors an avenue to participate in the growth story of India’s dynamic healthcare and allied industries. This launch reflects a strategic focus on sectors poised for continued expansion.